Restoring type VII collagen in skin

Su M. Lwin, John A. McGrath*

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review


New therapeutic hope is emerging for people with the rare inherited blistering skin disease recessive dystrophic epidermolysis bullosa (RDEB). Gurevich et al.1 have reported early-phase clinical trial data evaluating a topical herpes simplex virus 1 vector to restore missing type VII collagen in RDEB skin and heal wounds.

Original languageEnglish
Pages (from-to)273-275
Number of pages3
Issue number5
Publication statusPublished - 13 May 2022


Dive into the research topics of 'Restoring type VII collagen in skin'. Together they form a unique fingerprint.

Cite this